UW Biomedical Engineering awarded $2.9 million research grant ( nager for the Wisconsin Alumni Researc...)

(Date:11/20/2009)...O, Nov. 20 Veridiam (www.veridiam....size company category at the 2009 Workplace Excell...iego Society for Human Resources Management and re... practices. ,, Veridiam was one of nine winners...ompanies, honored at the recent awards ceremony. S...

(Date:11/20/2009)...TLE, Nov. 20 Cell Therap...d today that the Ninth Circuit Court of Appeals re...CTI should be allowed to pursue all of its claims ...he District Court for trial. CTI filed a complain... reimbursement consultant for CTI,s product TRISEN...

(Date:11/19/2009)...N, Nov. 19 Danish Prince Joachim i...ethanol plant in Kalundborg, Denmark, on Wednesday...first and largest 2nd generation ethanol demonstra... are used in the plant,s innovative process for co...nisco, was the first to market with commercial enz...

(Date:11/19/2009)..., Nov. 19 NeoStem, Inc. ...nt the following letter to its shareholders, discu...09, of China Biopharmaceuticals Holdings, Inc. (CH...d in the People,s Republic of China. The merger gi...yre Pharmaceutical Co. Ltd., CHBP,s primary operat...

Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2 Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2 DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2 NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2 NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3

[1] Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category [0] Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group [0] DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel [0] NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company

...mproved Technology Will Provide the Early Detectio...in Fish Farms and Wild Stocks -, HAMILTON, New Ze...une,17 ZyGEM Corp Ltd. and DIAGNOTEC S.A. today a...oduce molecular diagnostics for the,detection of i...ly pathogen,that attacks salmon and other fish spe...

...h Throughput Technology Identifies DNA Variations ... and Test Genome, OMAHA, Neb., June 17 Transgeno...t it is developing SURVEYOR,Endonuclease Adaptor-l...,throughput enabling technology for whole genome a...reference genome and a test genome. SEAL is,design...

...VER, June 17 Corgenix Medical Corporation,(OTC Bu...keter of,diagnostic test kits, announced today the...Charles H. Miranda, M.D., F.A.C.P., F.A.A.P., to i...nda join Luis Lopez, M.D., Corgenix Chairman and,C...ntific advisory board,members to three., "These t...

Other Biology Technology:ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon 2 ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon 3 Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 2 Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 3 Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 4 Corgenix Expands Scientific Advisory Board 2 Corgenix Expands Scientific Advisory Board 3

ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation Corgenix Expands Scientific Advisory Board

(Date:11/20/2009)...November 19, 2009 The estimated 4.6 million Ameri...k of developing respiratory symptoms due to poor a...naire study undertaken earlier this year by invest...eterinary Medicine. , The studywhich polled more...50 percent of individuals working in barns complai...

(Date:11/20/2009)...able in German . , In the current online is.... Stefanie Eyerich and Dr. Kilian Eyerich together...n and Istituto Dermopatico dell,Immacolata in Rome...sents a milestone on the way to developing new tre... as psoriasis and allergic reactions and potential...

(Date:11/20/2009)...new study, researchers report that a class of hear...ful, or harmful, effect on the heart, depending on...pears in the journal Circulation Research , found...d beta-receptors on the heart muscle offer the mos...rget only the beta-receptors can actually undermin...

[0] Barn personnel experience higher-than-average rates of respiratory symptoms [0] Discovery of new type of immune cells regulating inflammation in chronic diseases [0] Carvedilol shown to have unique characteristics among beta blockers

...lot-dissolving medication that is administered to ...ay help to reduce the risk of amputation following...ne issue of Archives of Surgery, one of the JAMA/A...ed essentially the same for the past 25 years, acc...Today, traditional therapy consists of tissue rewa...

...at the University of Central Florida is proving pr...ucoma, an eye disease that can cause blindness and...particle can safely get past the blood-brain barri...delivery,” said Sudipta Seal, an engineering profe... Processing and Analysis Center and the Nanoscienc...

...ions and other diseases of the brain is the blood-...ed therapeutic drugs from reaching the brain. Gran...ctious Diseases, part of the National Institutes o...tide) from the rabies virus can carry a strip of t... administration. Once delivered to the nerve cells...

Other Biology News:Clot-dissolving agent may be beneficial in treatment of severe frostbite 2 UCF nanoparticle offers promise for treating glaucoma 2 Blood-brain barrier breached by new therapeutic strategy 2

Clot-dissolving agent may be beneficial in treatment of severe frostbite UCF nanoparticle offers promise for treating glaucoma Blood-brain barrier breached by new therapeutic strategy

Rat Anti-Mouse Axl Monoclonal Antibody, Unconjugated, Clone 175128 from R&D Systems

Rabbit Anti-Human RXRA Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.

Human M-CSF from BioVision

Mouse Anti-Human IL-19 Monoclonal Antibody, Unconjugated, Clone 152112 from R&D Systems

Biology Products:

Rat Anti-Mouse Axl Monoclonal Antibody, Unconjugated, Clone 175128 from R&D Systems Rabbit Anti-Human RXRA Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.Human M-CSF from BioVision Mouse Anti-Human IL-19 Monoclonal Antibody, Unconjugated, Clone 152112 from R&D Systems

( nager for the Wisconsin Alumni Researc...)UW Biomedical Engineering awarded $2.9 million research grant